 Melissa Mahoney
Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyethylene Glycols | 17 | 2015 | 631 | 3.070 |
Why?
| | Neurons | 13 | 2011 | 1586 | 1.520 |
Why?
| | Biocompatible Materials | 9 | 2014 | 423 | 1.380 |
Why?
| | Tissue Engineering | 9 | 2014 | 422 | 1.380 |
Why?
| | Hydrogels | 9 | 2015 | 676 | 1.250 |
Why?
| | Embryonic Stem Cells | 4 | 2010 | 129 | 1.140 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 4 | 2011 | 77 | 1.050 |
Why?
| | Interleukin-10 | 5 | 2016 | 299 | 1.020 |
Why?
| | Cell Culture Techniques | 10 | 2015 | 359 | 0.890 |
Why?
| | Lactic Acid | 6 | 2012 | 306 | 0.810 |
Why?
| | Rats | 26 | 2016 | 5544 | 0.800 |
Why?
| | Neuroglia | 5 | 2011 | 171 | 0.740 |
Why?
| | Cell Survival | 9 | 2015 | 1124 | 0.660 |
Why?
| | Fibrin | 2 | 2010 | 82 | 0.630 |
Why?
| | Cell Differentiation | 9 | 2010 | 1985 | 0.630 |
Why?
| | Spinal Cord | 2 | 2012 | 371 | 0.580 |
Why?
| | Insulin-Secreting Cells | 3 | 2014 | 377 | 0.530 |
Why?
| | Cells, Cultured | 12 | 2011 | 4136 | 0.520 |
Why?
| | Brain-Derived Neurotrophic Factor | 4 | 2011 | 133 | 0.520 |
Why?
| | Genetic Therapy | 5 | 2016 | 297 | 0.510 |
Why?
| | Brain Tissue Transplantation | 4 | 2001 | 20 | 0.510 |
Why?
| | Brain | 7 | 2011 | 2711 | 0.500 |
Why?
| | Rats, Sprague-Dawley | 10 | 2011 | 2463 | 0.480 |
Why?
| | Cell Proliferation | 8 | 2010 | 2456 | 0.470 |
Why?
| | Neuralgia | 2 | 2016 | 133 | 0.440 |
Why?
| | Collagen | 2 | 2007 | 449 | 0.430 |
Why?
| | Drug Delivery Systems | 4 | 2010 | 356 | 0.430 |
Why?
| | Nerve Tissue | 3 | 2009 | 6 | 0.390 |
Why?
| | Animals | 32 | 2016 | 36882 | 0.390 |
Why?
| | Pancreas | 2 | 2015 | 320 | 0.360 |
Why?
| | Injections, Spinal | 5 | 2016 | 105 | 0.350 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 971 | 0.350 |
Why?
| | Fibroblast Growth Factor 2 | 2 | 2011 | 87 | 0.350 |
Why?
| | Nerve Growth Factor | 3 | 2006 | 31 | 0.340 |
Why?
| | Microscopy, Confocal | 5 | 2015 | 321 | 0.320 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2010 | 80 | 0.320 |
Why?
| | Fetus | 3 | 2006 | 797 | 0.320 |
Why?
| | Gene Transfer Techniques | 2 | 2010 | 174 | 0.310 |
Why?
| | DNA | 4 | 2010 | 1441 | 0.310 |
Why?
| | Free Radical Scavengers | 1 | 2009 | 87 | 0.310 |
Why?
| | Neovascularization, Physiologic | 1 | 2010 | 179 | 0.310 |
Why?
| | Thrombin | 1 | 2010 | 154 | 0.310 |
Why?
| | Free Radicals | 1 | 2009 | 113 | 0.300 |
Why?
| | Fibrinogen | 1 | 2010 | 170 | 0.300 |
Why?
| | Guided Tissue Regeneration | 1 | 2009 | 13 | 0.300 |
Why?
| | Collagen Type I | 1 | 2009 | 137 | 0.300 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2010 | 130 | 0.300 |
Why?
| | Plasmids | 1 | 2010 | 358 | 0.300 |
Why?
| | Fetal Tissue Transplantation | 4 | 2010 | 36 | 0.300 |
Why?
| | Tissue Scaffolds | 1 | 2010 | 209 | 0.280 |
Why?
| | Central Nervous System | 1 | 2010 | 262 | 0.280 |
Why?
| | Polyglycolic Acid | 4 | 2012 | 44 | 0.270 |
Why?
| | Islets of Langerhans | 2 | 2010 | 793 | 0.270 |
Why?
| | Stem Cells | 3 | 2010 | 595 | 0.250 |
Why?
| | Polymers | 2 | 2010 | 489 | 0.250 |
Why?
| | Choline O-Acetyltransferase | 3 | 2001 | 24 | 0.240 |
Why?
| | Neurites | 2 | 2005 | 48 | 0.240 |
Why?
| | Materials Testing | 4 | 2009 | 349 | 0.230 |
Why?
| | Endothelial Cells | 2 | 2010 | 784 | 0.230 |
Why?
| | Behavior, Animal | 3 | 2016 | 503 | 0.230 |
Why?
| | Retinal Degeneration | 3 | 2010 | 38 | 0.220 |
Why?
| | Pain | 1 | 2010 | 750 | 0.220 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2005 | 76 | 0.220 |
Why?
| | Glucose | 1 | 2009 | 1029 | 0.220 |
Why?
| | Retina | 3 | 2010 | 296 | 0.190 |
Why?
| | Nerve Growth Factors | 2 | 1999 | 78 | 0.180 |
Why?
| | Immunohistochemistry | 3 | 2011 | 1706 | 0.180 |
Why?
| | Cell Count | 3 | 2011 | 317 | 0.180 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2011 | 18 | 0.170 |
Why?
| | Models, Biological | 2 | 2006 | 1780 | 0.170 |
Why?
| | Cell Shape | 2 | 2010 | 57 | 0.170 |
Why?
| | Particle Size | 3 | 2011 | 391 | 0.160 |
Why?
| | PC12 Cells | 3 | 2009 | 40 | 0.150 |
Why?
| | Porosity | 2 | 2010 | 101 | 0.150 |
Why?
| | Cell Aggregation | 3 | 2015 | 26 | 0.150 |
Why?
| | Adenosine Triphosphate | 2 | 2010 | 481 | 0.130 |
Why?
| | Gene Expression Regulation | 3 | 2010 | 2574 | 0.120 |
Why?
| | Stem Cell Transplantation | 2 | 2007 | 177 | 0.120 |
Why?
| | Apoptosis | 3 | 2010 | 2542 | 0.120 |
Why?
| | Surface Properties | 2 | 2009 | 409 | 0.120 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 68 | 0.120 |
Why?
| | Human Embryonic Stem Cells | 1 | 2015 | 25 | 0.120 |
Why?
| | Enzymes | 1 | 2015 | 65 | 0.110 |
Why?
| | Cell Size | 2 | 2015 | 90 | 0.110 |
Why?
| | Fatigue | 1 | 2016 | 337 | 0.110 |
Why?
| | Prosthesis Implantation | 2 | 2011 | 151 | 0.100 |
Why?
| | Cell Line | 2 | 2010 | 2855 | 0.090 |
Why?
| | Astrocytes | 2 | 2011 | 210 | 0.090 |
Why?
| | Microspheres | 4 | 2010 | 134 | 0.090 |
Why?
| | Alzheimer Disease | 2 | 1999 | 567 | 0.090 |
Why?
| | Dipeptides | 1 | 2011 | 49 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 338 | 0.090 |
Why?
| | Microglia | 2 | 2011 | 249 | 0.090 |
Why?
| | Epidermal Growth Factor | 1 | 2011 | 176 | 0.090 |
Why?
| | Cell Enlargement | 1 | 2010 | 7 | 0.080 |
Why?
| | Proteins | 1 | 1996 | 1003 | 0.080 |
Why?
| | Parkinson Disease | 1 | 1996 | 542 | 0.080 |
Why?
| | 3T3 Cells | 1 | 2010 | 164 | 0.080 |
Why?
| | Compressive Strength | 1 | 2010 | 74 | 0.080 |
Why?
| | Pharmacokinetics | 1 | 2010 | 27 | 0.080 |
Why?
| | Molecular Weight | 1 | 2010 | 330 | 0.080 |
Why?
| | Gels | 1 | 2010 | 79 | 0.080 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 143 | 0.080 |
Why?
| | Coculture Techniques | 1 | 2010 | 240 | 0.080 |
Why?
| | Mechanical Phenomena | 1 | 2010 | 84 | 0.080 |
Why?
| | Elastic Modulus | 1 | 2010 | 123 | 0.080 |
Why?
| | Geography | 1 | 2010 | 202 | 0.080 |
Why?
| | Polyesters | 1 | 2010 | 77 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 372 | 0.080 |
Why?
| | Vimentin | 1 | 2009 | 52 | 0.080 |
Why?
| | Glucose Transporter Type 2 | 1 | 2009 | 15 | 0.080 |
Why?
| | Time Factors | 2 | 2010 | 6786 | 0.080 |
Why?
| | Esters | 1 | 2009 | 77 | 0.080 |
Why?
| | Cat Diseases | 1 | 2009 | 21 | 0.080 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 153 | 0.080 |
Why?
| | Absorption | 1 | 2009 | 59 | 0.080 |
Why?
| | Extracellular Matrix | 2 | 2014 | 532 | 0.080 |
Why?
| | Aldehydes | 1 | 2009 | 144 | 0.070 |
Why?
| | Blood-Brain Barrier | 1 | 2010 | 137 | 0.070 |
Why?
| | Anxiety | 1 | 2016 | 1052 | 0.070 |
Why?
| | Insulin | 2 | 2009 | 2394 | 0.070 |
Why?
| | Plasma | 1 | 2010 | 215 | 0.070 |
Why?
| | Glutathione | 1 | 2010 | 357 | 0.070 |
Why?
| | Haplorhini | 1 | 2008 | 51 | 0.070 |
Why?
| | Mitogens | 1 | 2007 | 59 | 0.070 |
Why?
| | Humans | 12 | 2015 | 136965 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1045 | 0.070 |
Why?
| | Growth Substances | 1 | 2006 | 148 | 0.060 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1073 | 0.060 |
Why?
| | Mass Spectrometry | 1 | 2009 | 737 | 0.060 |
Why?
| | Regenerative Medicine | 1 | 2006 | 50 | 0.060 |
Why?
| | Mice | 4 | 2015 | 17705 | 0.060 |
Why?
| | Diffusion | 1 | 2006 | 120 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2015 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 2007 | 1343 | 0.060 |
Why?
| | Pain Management | 1 | 2009 | 363 | 0.060 |
Why?
| | Fibroblasts | 1 | 2010 | 997 | 0.060 |
Why?
| | Resins, Synthetic | 1 | 2005 | 14 | 0.060 |
Why?
| | Biological Transport | 1 | 2006 | 401 | 0.060 |
Why?
| | Biomimetic Materials | 1 | 2005 | 71 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2010 | 883 | 0.060 |
Why?
| | Cell Communication | 1 | 2006 | 315 | 0.060 |
Why?
| | Cell Lineage | 1 | 2006 | 352 | 0.060 |
Why?
| | Nanoparticles | 1 | 2010 | 467 | 0.050 |
Why?
| | Cell Polarity | 1 | 2005 | 140 | 0.050 |
Why?
| | Fluorescent Dyes | 1 | 2005 | 315 | 0.050 |
Why?
| | Male | 6 | 2016 | 67386 | 0.050 |
Why?
| | Macrophages | 1 | 2010 | 1540 | 0.050 |
Why?
| | Solubility | 1 | 2001 | 241 | 0.040 |
Why?
| | Evoked Potentials, Visual | 2 | 2010 | 35 | 0.040 |
Why?
| | Biopolymers | 1 | 1999 | 30 | 0.040 |
Why?
| | Drug Implants | 1 | 1999 | 81 | 0.040 |
Why?
| | Electrophysiology | 2 | 2010 | 216 | 0.040 |
Why?
| | Superior Colliculi | 2 | 2010 | 42 | 0.040 |
Why?
| | Biotechnology | 1 | 1999 | 45 | 0.040 |
Why?
| | Culture Media | 1 | 1999 | 163 | 0.040 |
Why?
| | Cytokines | 1 | 2006 | 2070 | 0.040 |
Why?
| | Delayed-Action Preparations | 1 | 1999 | 173 | 0.040 |
Why?
| | Animals, Genetically Modified | 2 | 2010 | 244 | 0.040 |
Why?
| | Photic Stimulation | 2 | 2010 | 245 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3661 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 1999 | 138 | 0.030 |
Why?
| | Mathematics | 1 | 1996 | 101 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2016 | 87 | 0.030 |
Why?
| | Life Expectancy | 1 | 2016 | 70 | 0.030 |
Why?
| | Hyperalgesia | 1 | 2016 | 123 | 0.030 |
Why?
| | Polymerization | 1 | 2015 | 127 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2016 | 406 | 0.020 |
Why?
| | Motor Activity | 1 | 2016 | 714 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2139 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2015 | 1189 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2900 | 0.020 |
Why?
| | Peptides | 1 | 2015 | 975 | 0.020 |
Why?
| | Cats | 1 | 2009 | 220 | 0.020 |
Why?
| | Rats, Mutant Strains | 1 | 2007 | 24 | 0.020 |
Why?
| | Head Movements | 1 | 2007 | 20 | 0.020 |
Why?
| | Motion Perception | 1 | 2007 | 16 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3393 | 0.020 |
Why?
| | Transcription Factors | 1 | 2015 | 1705 | 0.020 |
Why?
| | Graft Survival | 1 | 2009 | 523 | 0.020 |
Why?
| | Chronic Disease | 1 | 2009 | 1774 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2371 | 0.010 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 1999 | 36 | 0.010 |
Why?
| | Succinimides | 1 | 1999 | 19 | 0.010 |
Why?
| | Fluorescein | 1 | 1999 | 24 | 0.010 |
Why?
| | Dimerization | 1 | 1999 | 195 | 0.010 |
Why?
| | Drug Stability | 1 | 1999 | 160 | 0.010 |
Why?
| | Polyvinyls | 1 | 1999 | 21 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 1999 | 168 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 1999 | 234 | 0.010 |
Why?
| | Biodegradation, Environmental | 1 | 1999 | 86 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 1999 | 264 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 318 | 0.010 |
Why?
| | Drug Carriers | 1 | 1999 | 126 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1999 | 577 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2007 | 4276 | 0.010 |
Why?
| | Kinetics | 1 | 1999 | 1635 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 10664 | 0.010 |
Why?
| | Female | 2 | 2011 | 73002 | 0.010 |
Why?
|
|
Mahoney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|